File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014

TitleProceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014
Authors
KeywordsImmunologic reconstitution after transplantation
Cellular therapy
Post-transplantation cyclophosphamide
T cell depleted
Haploidentical transplantation
Issue Date2016
Citation
Biology of Blood and Marrow Transplantation, 2016, v. 22, n. 4, p. 594-604 How to Cite?
Abstract© 2016 American Society for Blood and Marrow Transplantation. Significant progress has been made over the past decade in haploidentical transplantation, with the development of novel methods to control intense alloreactive reactions generated in the major HLA-mismatched setting. Application of post-transplantation cyclophosphamide has gained worldwide acceptance as an effective and low-cost way to perform this type of transplantation, with outcomes now similar to those from HLA-matched unrelated donors. These advances have resulted in improved treatment-related mortality, whereas disease relapse has emerged as the most common cause of treatment failure. In addition, improvements in immunologic reconstitution after transplantation are much needed, not only in haploidentical transplantation but in all forms of stem cell transplantation. This symposium has focused on some of the most promising methods to control alloreactivity in this form of transplantation and application of cellular therapy to prevent disease relapse after transplantation, as well as understanding immunologic reconstitution and foreseeable approaches to improve immune recovery after transplantation.
Persistent Identifierhttp://hdl.handle.net/10722/294513
ISSN
2022 Impact Factor: 4.3
2020 SCImago Journal Rankings: 2.301
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorAl Malki, Monzr M.-
dc.contributor.authorHorowitz, Mary-
dc.contributor.authorHandgretinger, Rupert-
dc.contributor.authorLeung, Wing-
dc.contributor.authorRoy, Denis Claude-
dc.contributor.authorHuang, Xiao Jun-
dc.contributor.authorFuchs, Ephraim-
dc.contributor.authorLocatelli, Franco-
dc.contributor.authorBlaise, Didier-
dc.contributor.authorMineishi, Shin-
dc.contributor.authorMartelli, Massimo-
dc.contributor.authorMiller, Jeffrey-
dc.contributor.authorJune, Carl-
dc.contributor.authorAi, Hui sheng-
dc.contributor.authorLuznik, Leo-
dc.contributor.authorMavilio, Domenico-
dc.contributor.authorLugli, Enrico-
dc.contributor.authorvan den Brink, Marcel R.M.-
dc.contributor.authorChamplin, Richard E.-
dc.contributor.authorCiurea, Stefan O.-
dc.date.accessioned2020-12-03T08:22:54Z-
dc.date.available2020-12-03T08:22:54Z-
dc.date.issued2016-
dc.identifier.citationBiology of Blood and Marrow Transplantation, 2016, v. 22, n. 4, p. 594-604-
dc.identifier.issn1083-8791-
dc.identifier.urihttp://hdl.handle.net/10722/294513-
dc.description.abstract© 2016 American Society for Blood and Marrow Transplantation. Significant progress has been made over the past decade in haploidentical transplantation, with the development of novel methods to control intense alloreactive reactions generated in the major HLA-mismatched setting. Application of post-transplantation cyclophosphamide has gained worldwide acceptance as an effective and low-cost way to perform this type of transplantation, with outcomes now similar to those from HLA-matched unrelated donors. These advances have resulted in improved treatment-related mortality, whereas disease relapse has emerged as the most common cause of treatment failure. In addition, improvements in immunologic reconstitution after transplantation are much needed, not only in haploidentical transplantation but in all forms of stem cell transplantation. This symposium has focused on some of the most promising methods to control alloreactivity in this form of transplantation and application of cellular therapy to prevent disease relapse after transplantation, as well as understanding immunologic reconstitution and foreseeable approaches to improve immune recovery after transplantation.-
dc.languageeng-
dc.relation.ispartofBiology of Blood and Marrow Transplantation-
dc.subjectImmunologic reconstitution after transplantation-
dc.subjectCellular therapy-
dc.subjectPost-transplantation cyclophosphamide-
dc.subjectT cell depleted-
dc.subjectHaploidentical transplantation-
dc.titleProceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014-
dc.typeArticle-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1016/j.bbmt.2016.01.001-
dc.identifier.pmid26806585-
dc.identifier.pmcidPMC7104805-
dc.identifier.scopuseid_2-s2.0-84960481145-
dc.identifier.volume22-
dc.identifier.issue4-
dc.identifier.spage594-
dc.identifier.epage604-
dc.identifier.eissn1523-6536-
dc.identifier.isiWOS:000373093500003-
dc.identifier.issnl1083-8791-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats